Krejci P - Search Results

1

Phenotype-genotype correlations in patients with Marinesco-Sjögren syndrome.

Ezgu F, Krejci P, Li S, de Sousa C, Graham JM Jr, Hansmann I, He W, Porpora K, Wand D, Wertelecki W, Schneider A, Wilcox WR. Ezgu F, et al. Among authors: krejci p. Clin Genet. 2014 Jul;86(1):74-84. doi: 10.1111/cge.12230. Epub 2013 Jul 30. Clin Genet. 2014. PMID: 23829326

2

FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells.

Krejci P, Bryja V, Pachernik J, Hampl A, Pogue R, Mekikian P, Wilcox WR. Krejci P, et al. Exp Cell Res. 2004 Jul 1;297(1):152-64. doi: 10.1016/j.yexcr.2004.03.011. Exp Cell Res. 2004. PMID: 15194433

3

Mutations in the EVC1 gene are not a common finding in the Ellis-van Creveld and short rib-polydactyly type III syndromes.

Takamine Y, Krejci P, Mekikian PB, Wilcox WR. Takamine Y, et al. Among authors: krejci p. Am J Med Genet A. 2004 Sep 15;130A(1):96-7. doi: 10.1002/ajmg.a.20579. Am J Med Genet A. 2004. PMID: 15368503 No abstract available.

4

Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis.

Krejci P, Masri B, Fontaine V, Mekikian PB, Weis M, Prats H, Wilcox WR. Krejci P, et al. J Cell Sci. 2005 Nov 1;118(Pt 21):5089-100. doi: 10.1242/jcs.02618. Epub 2005 Oct 18. J Cell Sci. 2005. PMID: 16234329

5

The fibroblast growth factors in multiple myeloma.

Krejci P, Mekikian PB, Wilcox WR. Krejci P, et al. Leukemia. 2006 Jun;20(6):1165-8. doi: 10.1038/sj.leu.2404202. Leukemia. 2006. PMID: 16598309 No abstract available.

6

Bisindolylmaleimide I suppresses fibroblast growth factor-mediated activation of Erk MAP kinase in chondrocytes by preventing Shp2 association with the Frs2 and Gab1 adaptor proteins.

Krejci P, Masri B, Salazar L, Farrington-Rock C, Prats H, Thompson LM, Wilcox WR. Krejci P, et al. J Biol Chem. 2007 Feb 2;282(5):2929-36. doi: 10.1074/jbc.M606144200. Epub 2006 Dec 4. J Biol Chem. 2007. PMID: 17145761 Free article.

7

Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligands expressed in human fetal growth plate cartilage.

Krejci P, Krakow D, Mekikian PB, Wilcox WR. Krejci P, et al. Pediatr Res. 2007 Mar;61(3):267-72. doi: 10.1203/pdr.0b013e318030d157. Pediatr Res. 2007. PMID: 17314681

8

Simple, mammalian cell-based assay for identification of inhibitors of the Erk MAP kinase pathway.

Krejci P, Pejchalova K, Wilcox WR. Krejci P, et al. Invest New Drugs. 2007 Aug;25(4):391-5. doi: 10.1007/s10637-007-9054-7. Epub 2007 Apr 26. Invest New Drugs. 2007. PMID: 17458503

9

C-natriuretic peptide: an important regulator of cartilage.

Pejchalova K, Krejci P, Wilcox WR. Pejchalova K, et al. Among authors: krejci p. Mol Genet Metab. 2007 Nov;92(3):210-5. doi: 10.1016/j.ymgme.2007.06.014. Epub 2007 Aug 6. Mol Genet Metab. 2007. PMID: 17681481 Review.

10

A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells.

Salazar L, Kashiwada T, Krejci P, Muchowski P, Donoghue D, Wilcox WR, Thompson LM. Salazar L, et al. Among authors: krejci p. Hum Mol Genet. 2009 Jun 1;18(11):1951-61. doi: 10.1093/hmg/ddp116. Epub 2009 Mar 13. Hum Mol Genet. 2009. PMID: 19286672 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters